0000899243-21-031417.txt : 20210803 0000899243-21-031417.hdr.sgml : 20210803 20210803210654 ACCESSION NUMBER: 0000899243-21-031417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210730 FILED AS OF DATE: 20210803 DATE AS OF CHANGE: 20210803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NELSEN ROBERT CENTRAL INDEX KEY: 0001219042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40676 FILM NUMBER: 211141960 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILLIS STEVEN CENTRAL INDEX KEY: 0001229592 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40676 FILM NUMBER: 211141958 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burow Kristina CENTRAL INDEX KEY: 0001569248 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40676 FILM NUMBER: 211141959 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ARCH Venture Fund XI, L.P. CENTRAL INDEX KEY: 0001831802 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40676 FILM NUMBER: 211141963 BUSINESS ADDRESS: STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 773-380-6600 MAIL ADDRESS: STREET 1: 8755 W. HIGGINS ROAD, SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ARCH Venture Partners XI, L.P. CENTRAL INDEX KEY: 0001847567 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40676 FILM NUMBER: 211141962 BUSINESS ADDRESS: STREET 1: 8755 W HIGGINS RD. STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 7733806600 MAIL ADDRESS: STREET 1: 8755 W HIGGINS RD. STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ARCH Venture Partners XI, LLC CENTRAL INDEX KEY: 0001847601 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40676 FILM NUMBER: 211141961 BUSINESS ADDRESS: STREET 1: 8755 W HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 7733806600 MAIL ADDRESS: STREET 1: 8755 W HIGGINS ROAD STREET 2: SUITE 1025 CITY: CHICAGO STATE: IL ZIP: 60631 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DA32 Life Science Tech Acquisition Corp. CENTRAL INDEX KEY: 0001863294 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 863352988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: (212) 551-1600 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-30 0 0001863294 DA32 Life Science Tech Acquisition Corp. DALS 0001831802 ARCH Venture Fund XI, L.P. DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 0 0 1 0 0001847567 ARCH Venture Partners XI, L.P. DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 0 0 1 0 0001847601 ARCH Venture Partners XI, LLC DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 0 0 1 0 0001219042 NELSEN ROBERT DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 0 0 1 0 0001569248 Burow Kristina DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 0 0 1 0 0001229592 GILLIS STEVEN DA32 LIFE SCIENCE TECH ACQUISITION CORP 345 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10010 0 0 1 0 Class A Common Stock 2021-07-30 4 P 0 1600000 10.00 A 1600000 D Class A Common Stock 2021-07-30 4 J 0 650000 10.00 A 2250000 I Through A32 ponsor LC ARCH Venture Fund XI, L.P. purchased 1,600,000 shares of the Issuer's Class A common stock for $10.00 per share in the Issuer's initial public offering. This Form 4 is filed jointly by ARCH Venture Fund XI, L.P. ("AVF"), ARCH Venture Partners XI, L.P. ("AVP LP"), ARCH Venture Partners XI, LLC ("AVP LLC"), Kristina Burow, Robert Nelsen and Steven Gillis (collectively, the "Reporting Persons"). Keith Crandell has direct ownership of the Issuer's Class B Common Stock, as well as indirect pecuniary ownership of the Issuer's Class A common stock and Class B Common Stock and is filing his own Form 4 separately. Burow, Crandell, Nelsen and Gillis comprise the investment committee of AVP LLC (the AVP X Committee Members). Each of the Reporting Persons is a member of a Section 13(d) group. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein. DA32 Sponsor LLC ("Sponsor") purchased 650,000 shares of Class A common stock directly from the Issuer in a private placement for $10.00 per share, concurrently with the Issuer's initial public offering. As a managing member of Sponsor, AVF may be deemed to beneficially own the securities owned directly by Sponsor. As the sole general partner of AVF, AVP LP may be deemed to beneficially own the securities owned directly by Sponsor. As the sole general partner of AVP LP, AVP LLC may be deemed to beneficially own securities owned directly by Sponsor. As the members of the investment committee, each of the AVP X Committee Members may be deemed to beneficially own securities owned directly by Sponsor. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of such Reporting Person's pecuniary interest therein. See Exhibit 99.1 - Joint Filer Information, which is incorporated herein by reference and describes in further detail the relationships of the Reporting Persons to the Issuer. Henrikki Harsu, Attorney-in-Fact: Power of Attorney, which is hereby incorporated by reference to Exhibit 24.1, 24.2, 24.3, 24.4, 24.5 and 24.6 to a Form 3 with regard to DA32 Life Science Tech Acquisition Corp. filed with the Securities and Exchange Commission on July 27, 2021 by ARCH Venture Fund XI, L.P., ARCH Venture Partners XI, L.P., ARCH Venture Partners XI, LLC, Kristina Burow, Robert Nelsen and Steven Gillis. /s/ Henrikki Harsu, Attorney-in-Fact for ARCH Venture Fund XI, L.P. 2021-08-03 /s/ Henrikki Harsu, Attorney-in-Fact for ARCH Venture Partners XI, L.P. 2021-08-03 /s/ Henrikki Harsu, Attorney-in-Fact for ARCH Venture Partners XI, LLC 2021-08-03 /s/ Henrikki Harsu, Attorney-in-Fact for Robert Nelsen 2021-08-03 /s/ Henrikki Harsu, Attorney-in-Fact for Kristina Burow 2021-08-03 /s/ Henrikki Harsu, Attorney-in-Fact for Steven Gillis 2021-08-03 EX-99.1 2 attachment1.htm EX-99.1 DOCUMENT

                            Joint Filer Information

Name of Joint Filer:                         ARCH Venture Fund XI, L.P.

Address of Joint Filer:                      345 Park Avenue South, 12th Floor
                                             New York, NY 10010

Relationship of Joint Filer to Issuer:       10% Owner

Issuer Name and Ticker or Trading Symbol:    DA32 Life Science Tech Acquisition
                                             Corp. [DALS]
Date of Event Requiring Statement:
(Month/Day/Year):                            07/30/2021


Name of Joint Filer:                         ARCH Venture Partners XI, L.P.

Address of Joint Filer:                      345 Park Avenue South, 12th Floor
                                             New York, NY 10010

Relationship of Joint Filer to Issuer:       10% Owner

Issuer Name and Ticker or Trading Symbol:    DA32 Life Science Tech Acquisition
                                             Corp. [DALS]
Date of Event Requiring Statement:
(Month/Day/Year):                            07/30/2021


Name of Joint Filer:                         ARCH Venture Partners XI, LLC

Address of Joint Filer:                      345 Park Avenue South, 12th Floor
					     New York, NY 10010

Relationship of Joint Filer to Issuer:       10% Owner

Issuer Name and Ticker or Trading Symbol:    DA32 Life Science Tech Acquisition
                                             Corp. [DALS]

Date of Event Requiring Statement:
(Month/Day/Year):                            07/30/2021


Name of Joint Filer:                         Robert Nelsen

Address of Joint Filer:                      345 Park Avenue South, 12th Floor
                                             New York, NY 10010

Relationship of Joint Filer to Issuer:       10% Owner

Issuer Name and Ticker or Trading Symbol:    DA32 Life Science Tech Acquisition
                                             Corp. [DALS]

Date of Event Requiring Statement:
(Month/Day/Year):                            07/30/2021


Name of Joint Filer:                         Kristina Burow

Address of Joint Filer:                      345 Park Avenue South, 12th Floor
                                             New York, NY 10010

Relationship of Joint Filer to Issuer:       10% Owner

Issuer Name and Ticker or Trading Symbol:    DA32 Life Science Tech Acquisition
                                             Corp. [DALS]

Date of Event Requiring Statement:
(Month/Day/Year):                            07/30/2021


Name of Joint Filer:                         Steven Gillis

Address of Joint Filer:                      345 Park Avenue South, 12th Floor
                                             New York, NY 10010

Relationship of Joint Filer to Issuer:       10% Owner

Issuer Name and Ticker or Trading Symbol:    DA32 Life Science Tech Acquisition
                                             Corp. [DALS]

Date of Event Requiring Statement:
(Month/Day/Year):                            07/30/2021